- Home
- INTG vs ESLA Comparison
INTG vs ESLA Comparison
Compare INTG & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTG | ESLA |
|---|---|---|
| Founded | 1965 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 60.9M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | INTG | ESLA |
|---|---|---|
| Price | $42.23 | $1.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 12.2K | ★ 160.4K |
| Earning Date | 05-13-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $74,753,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $90.24 | ★ N/A |
| Revenue Growth | ★ 4.43 | N/A |
| 52 Week Low | $10.37 | $0.78 |
| 52 Week High | $43.84 | $3.15 |
Technical Indicators
Market Signals| Indicator | INTG | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 54.27 |
| Support Level | $31.41 | $1.48 |
| Resistance Level | $41.75 | $2.07 |
| Average True Range (ATR) | 2.30 | 0.17 |
| MACD | 0.72 | -0.04 |
| Stochastic Oscillator | 82.03 | 38.38 |
Price Performance
Historical ComparisonAbout INTG Intergroup Corporation (The)
The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.